Company attributes
Patents Assigned (Count)
8
Country
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
GEMoaB Monoclonals is a cellular immunotherapies for cancer.